TickerFacts.

UL Solutions Inc. (ULS): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$403.00M
Year ended 2025-12-31
$436.00M
Trailing 12 months to 2026-06-30
+24.7%
3-year compound annual growth
2022-12-31: $208.00M2023-12-31: $252.00M2024-12-31: $287.00M2025-12-31: $403.00M$403.00M
2022-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$403.00M+40.4%2026-02-19, From 2025-01-01
2024-12-31$287.00M+13.9%2026-02-19, From 2024-01-01
2023-12-31$252.00M+21.2%2026-02-19, From 2023-01-01
2022-12-31$208.00Mn/a2025-02-20, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
UL Solutions Inc. (ULS)2025-12-31$403.00M+40.4%
NeoGenomics Inc (NEO)2025-12-31-$21.78Mn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$412.9Kn/m

Compare ULS, NEO, FUNI side by side · Screen every company in Services-Testing Laboratories ↗